search
Back to results

Therapy for Depression With Co-occurring Panic or Anxiety Symptoms

Primary Purpose

Depression, Anxiety Disorders, Panic Disorder

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Interpersonal Psychotherapy (IPT)
IPT for Depression with Co-occurring Panic and Anxiety Symptoms (IPT-PS)
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring Mood Disorders, Psychotherapy, Comorbidity

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: DSM-IV diagnosis of major depression with co-existing panic or anxiety symptoms. Exclusion Criteria: History of manic episode(s). Patients who have had hypomanic episodes in the past will be accepted into the study, provided they meet other admission criteria and are not presenting in a current hypomanic or mixed episode. History of schizophrenia or schizoaffective disorder. Organic affective syndrome. Unspecified functional psychosis. Anorexia nervosa or bulimia nervosa. Patients meeting criteria for an eating disorder not otherwise specified will not be excluded. Chronic drug or alcohol abuse/dependence within the past 2 years. Patients with abuse related to episodes will not be excluded. DSM-IV criteria for borderline or antisocial personality disorder. Patients who meet criteria for other Axis II disorders will not be excluded. Inpatient treatment due to suicide risk or psychotic symptoms. Index episode secondary to the effect of medically prescribed drugs. Significant or untreated medical illness, including cardiovascular disorder, renal or liver disease, epilepsy, untreated hypertension, or unstabilized endocrine disease. Medical illness that would interfere with the best treatment strategy for the potential participant. Current treatment with an antidepressant. Patients on a stable dose of anxiolytics for at least 3 months prior to study participation who are able to maintain this dosage throughout the study will not be excluded. Pregnant and breast-feeding women will be accepted into the study, but will not be prescribed adjunctive medications.

Sites / Locations

  • Western Psychiatric Institute and Clinic - Depression and Manic Depression Program

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
January 7, 2003
Last Updated
June 21, 2013
Sponsor
University of Pittsburgh
search

1. Study Identification

Unique Protocol Identification Number
NCT00051207
Brief Title
Therapy for Depression With Co-occurring Panic or Anxiety Symptoms
Official Title
Interpersonal Psychotherapy for Depression With Co-occurring Panic and Anxiety Symptoms (IPT-PS)
Study Type
Interventional

2. Study Status

Record Verification Date
December 2007
Overall Recruitment Status
Completed
Study Start Date
November 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Pittsburgh

4. Oversight

5. Study Description

Brief Summary
This 6-month study, with a 3-month follow up period, will compare the effectiveness of new and traditional psychotherapies for depression with panic or anxiety symptoms.
Detailed Description
Many depressed patients also experience significant symptoms of panic or anxiety. This study will compare the effectiveness of a new therapy called interpersonal psychotherapy for depression with panic or anxiety symptoms (IPT-PS) with that of traditional interpersonal psychotherapy for depression (IPT). Participants are randomly assigned to receive up to 24 weeks of treatment with either IPT-PS or traditional IPT. Improvements in interpersonal functioning, quality of life, and symptoms of depression and anxiety will be assessed at the end of therapy and at a 3-month follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety Disorders, Panic Disorder
Keywords
Mood Disorders, Psychotherapy, Comorbidity

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
36 (false)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Interpersonal Psychotherapy (IPT)
Intervention Type
Behavioral
Intervention Name(s)
IPT for Depression with Co-occurring Panic and Anxiety Symptoms (IPT-PS)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: DSM-IV diagnosis of major depression with co-existing panic or anxiety symptoms. Exclusion Criteria: History of manic episode(s). Patients who have had hypomanic episodes in the past will be accepted into the study, provided they meet other admission criteria and are not presenting in a current hypomanic or mixed episode. History of schizophrenia or schizoaffective disorder. Organic affective syndrome. Unspecified functional psychosis. Anorexia nervosa or bulimia nervosa. Patients meeting criteria for an eating disorder not otherwise specified will not be excluded. Chronic drug or alcohol abuse/dependence within the past 2 years. Patients with abuse related to episodes will not be excluded. DSM-IV criteria for borderline or antisocial personality disorder. Patients who meet criteria for other Axis II disorders will not be excluded. Inpatient treatment due to suicide risk or psychotic symptoms. Index episode secondary to the effect of medically prescribed drugs. Significant or untreated medical illness, including cardiovascular disorder, renal or liver disease, epilepsy, untreated hypertension, or unstabilized endocrine disease. Medical illness that would interfere with the best treatment strategy for the potential participant. Current treatment with an antidepressant. Patients on a stable dose of anxiolytics for at least 3 months prior to study participation who are able to maintain this dosage throughout the study will not be excluded. Pregnant and breast-feeding women will be accepted into the study, but will not be prescribed adjunctive medications.
Facility Information:
Facility Name
Western Psychiatric Institute and Clinic - Depression and Manic Depression Program
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Therapy for Depression With Co-occurring Panic or Anxiety Symptoms

We'll reach out to this number within 24 hrs